San Diego, CA, United States of America

Richard Truong

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Lin Bioscience Inc., Lin Bioscience Pty Ltd.. Active years: 2021-2025.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Richard Truong: Innovator in Cancer Treatment

Introduction

Richard Truong is a notable inventor based in San Diego, California. He has made significant contributions to the field of cancer treatment through his innovative work on tubulin inhibitors. With a total of two patents to his name, Truong is dedicated to advancing medical science and improving patient outcomes.

Latest Patents

Truong's latest patents focus on tubulin inhibitors, which are compounds designed to treat various diseases, particularly cancer. These patents detail pharmaceutical compositions and methods of treatment aimed at addressing brain cancers and metastatic cancers that spread to the brain. His research is pivotal in developing effective therapies for challenging cancer types.

Career Highlights

Truong is currently associated with Lin Bioscience Pty Ltd., where he continues to push the boundaries of cancer research. His work is characterized by a commitment to finding innovative solutions that can lead to better treatment options for patients suffering from cancer.

Collaborations

Some of his notable coworkers include Tom Lin and Cheng-Chi Irene Wang, who collaborate with him in his research endeavors. Their combined expertise contributes to the advancement of their projects and the overall mission of Lin Bioscience.

Conclusion

Richard Truong is a dedicated inventor whose work in developing tubulin inhibitors is making a significant impact in the fight against cancer. His innovative approach and collaboration with talented colleagues position him as a key figure in the medical research community.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…